
UTHR · Nasdaq
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $3.18B | $2.88B | $2.33B | $1.94B | $1.69B | $1.48B | $1.45B | $1.63B |
| Cost of Revenue | $384.40M | $309.70M | $257.50M | $151.60M | $122.50M | $108.10M | $117.60M | $198.70M |
| Gross Profit | $2.80B | $2.57B | $2.07B | $1.78B | $1.56B | $1.38B | $1.33B | — |
| Research & Development | $550.00M | $481.00M | $408.00M | $322.90M | $540.10M | $357.70M | $1.18B | $357.90M |
| Selling, General & Administrative | $755.80M | $709.70M | $477.10M | $482.10M | $467.00M | — | — | $265.80M |
| Operating Expenses | $1.69B | $1.50B | $1.14B | $956.60M | $1.13B | $889.70M | $1.64B | $822.40M |
| Operating Income | $1.49B | $1.38B | $1.18B | $979.70M | $555.90M | $593.60M | -$187.60M | $805.40M |
| Interest Expense | — | — | $59.30M | $32.40M | $18.60M | $23.50M | $44.20M | $13.90M |
| Other Income / (Expense) | $221.40M | $162.00M | $89.40M | -$29.10M | $38.00M | $45.30M | $22.60M | -$46.50M |
| Income Before Taxes | $1.71B | $1.54B | $1.27B | $950.60M | $593.90M | $638.90M | -$165.00M | $758.90M |
| Provision for Income Taxes | $379.20M | $343.90M | $289.50M | $223.30M | $118.10M | $124.10M | -$60.50M | $169.70M |
| Net Income | $1.33B | $1.20B | $984.80M | $727.30M | $475.80M | — | -$104.50M | $589.20M |
| Basic EPS | $30.13 | $26.44 | $21.04 | $15.98 | $10.60 | $11.65 | -$2.39 | $13.54 |
| Diluted EPS | $27.86 | $24.64 | $19.81 | $15.00 | $10.06 | $11.54 | -$2.39 | $13.39 |
| Basic Shares Outstanding | 44.30M | 45.20M | 46.80M | 45.50M | 44.90M | 44.20M | 43.80M | 43.50M |
| Diluted Shares Outstanding | 47.90M | 48.50M | 49.70M | 48.50M | 47.30M | 44.60M | 43.80M | 44.00M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $26.07 | $23.91 | $27.35 | 7 | ↑1 ↓1 |
| Dec 2027 | $30.36 | $23.09 | $36.10 | 7 | ↑2 ↓1 |
| Dec 2028 | $35.30 | $31.56 | $39.69 | 4 | ↑3 ↓0 |
| Dec 2029 | $44.14 | $42.25 | $46.03 | 2 | ↑1 ↓0 |